PlasmaMed Lab at the IWCPT 2019

Five members of the PlasmaMed lab, including leader Dr. Cristina Canal, have attended the  6th International Workshop on Plasma for Cancer Treatment - IWPCT 2019 in Antwerp (Belgium), held on April 1-3rd, 2019.

Dr. Labay had an oral talk presenting his work on "Plasma-treated gelatine/alginate hydrogels as reservoir of RONS" (C. Labay, M. Roldán, M.P. Ginebra, C. Canal).

Dr. Tornin, Ms. Hamouda and Mr. Mateu had a poster presentation each to present their works on:

• J. Tornín, M. Mateu-Sanz, A. Rodriguez, R. Rodríguez, C. Canal. Pyruvate plays a main role to ensure the antitumoral selectivity of cold atmospheric plasma in osteosarcoma
• I. Hamouda, C. Labay, M.P. Ginebra, E. Nicol, C. Canal. Evaluation of a photo-crosslinked hydrogel as carrier of reactive species generated by plasma jets * Best Poster Presentation Prize
• M. Mateu, J. Tornín, C. Canal. Cold Atmospheric Plasma-activated Ringer's solution selectively induce cytotoxic effects on human osteosarcoma cells

Dr. Cristina Canal is a member of the IWPCT 2019 International Scientific Committee.

The Conference sessions include topics such as Plasma sources and plasma equipment used for cancer treatment; Plasma-cancer interactions: experiments, modeling and simulation; Destruction of cancer cells by plasma; Mechanisms of plasma selectivity towards cancer cells; Plasma-liquid interaction / plasma chemistry in biological liquids / plasma activated media for cancer treatment; and Clinical and animal studies of cancer treatment by plasma.